Reverse DCF
What growth does the market imply for ADVENZYMES?
Working backwards from the current price to find the FCF growth assumption baked in.
aggressive
16.4% implied annual FCF growth
The market is pricing in above-average growth. Achievable for a high-quality business but leaves limited margin for error — any slowdown could hurt the price.
Current Price
₹361
Historical Growth
0.7%
FCF Yield
2.58%
Price / FCF
38.8x
Plain English
To justify today's price of ₹361.40, ADVENZYMES.NS needs to grow its free cash flow at 16.4% per year for the next 10 years. That is 15.7% faster than its historical growth rate of 0.7%. This is optimistic but not impossible for a high-quality business. The stock leaves little room for error — any slowdown could hurt the price.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | 0.7% | ₹114 | -68.4% |
| Half implied | 8.2% | ₹196 | -45.8% |
| GDP rate | 10.0% | ₹224 | -38.1% |
| Implied | 16.4% | ₹361 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At 0.7% growth, the model values ADVENZYMES at ₹114, below today's ₹361.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.